FindTrial
Sign In

Study for the effect of Traditional Chinese medicine in the prevention of novel coronavirus pneumonia (COVID-1) in the high risk area

Study for the effect of Traditional Chinese medicine in the prevention of novel coronavirus pneumonia (COVID-1) in the high risk area

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ITMCTR
Registry ID
ITMCTR2000003351
Enrollment
Unknown
Registered
2020-05-28
Start date
2020-05-29
Completion date
Unknown
Last updated
2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Novel Coronavirus Pneumonia (COVID-19)

Interventions

Case series:Chushifangyi prescription

Sponsors

The affiliated Hospital to Changchun University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Aged >=18 years old; 2. On the basis of routine protection, adopted Chushifangyi prescription to preventive COVID-19; 3. Agreed to participate in this clinical observation.

Exclusion criteria

Exclusion criteria: 1. People who are allergic to known drug ingredients; 2. Those who can not take Chushifangyi preparation; 3. Subject with the mental disorders or combined with liver, kidney and other major diseases; 4. Inability to work with data collecte or dyslexia; 5. Others situation are not suitable for this study.

Design outcomes

Primary

MeasureTime frame
Confirmed 2019-ncov pneumonia;—

Secondary

MeasureTime frame
Observation of symptoms of traditional Chinese medicine;—

Countries

China

Contacts

Public ContactShi Li

Affiliated Hospital of Changchun University of Traditional Chinese Medicine

15948000558@163.com+86 15948000558

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026